## Abstract In some patients, therapy with botulinum toxin type A (BTβA) becomes ineffective due to formation of antibodies (BTβAβAB). The time course of BTβAβAB titres after cessation of BTβA therapy was quantitatively studied to determine whether and when they might drop. Thirteen patients (eight
β¦ LIBER β¦
Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failure
β Scribed by D. Dressler; Hans Bigalke; R. Benecke
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 183 KB
- Volume
- 250
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Botulinum toxin antibody type A titres a
β
Dirk Dressler; Hans Bigalke
π
Article
π
2001
π
John Wiley and Sons
π
English
β 145 KB
Clinical use of non-a botulinum toxins:
β
Dirk Dressler; Roberto Eleopra
π
Article
π
2006
π
Springer-Verlag
π
English
β 977 KB
Clinical use of non-a botulinum toxins:
β
Roberto Eleopra; Valeria Tugnoli; Rocco Quatrale; Ornella Rossetto; Cesare Monte
π
Article
π
2006
π
Springer-Verlag
π
English
β 850 KB
Botulinum toxin type A therapy during pr
β
Cynthia L. Bodkin; Kenneth B. Maurer; Zbigniew K. Wszolek
π
Article
π
2005
π
John Wiley and Sons
π
English
β 43 KB
Botulinum toxin type A therapy during pr
β
William J. Newman; Thomas L. Davis; Bismal B. Padaliya; Cassondra D. Covington;
π
Article
π
2004
π
John Wiley and Sons
π
English
β 41 KB
## Abstract Injection with botulinum toxin type A (Botox) is a safe and efficacious treatment for idiopathic cervical dystonia. We present the first case report of clinical Botox treatment during pregnancy. This patient underwent four apparently uncomplicated fullβterm pregnancies while receiving r
Botulinum toxin type B de novo therapy o
β
D. Dressler; H. Bigalke
π
Article
π
2005
π
Springer
π
English
β 188 KB